Progression-free survival and quality of life in metastatic breast cancer: The patient perspective

2021 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J Clin, 71, 10.3322/caac.21660 Bray, 2004, The changing global patterns of female breast cancer incidence and mortality, Breast Cancer Res, 6 Mariotto, 2017, Estimation of the number of women living with metastatic breast cancer in the United States, Cancer Epidemiology, Biomarkers & Prevention., 26 Sundquist, 2017, Improved survival in metastatic breast cancer 1985-2016, Breast, 31, 46, 10.1016/j.breast.2016.10.005 Cardoso F, Spence D, Mertz S, et al. Global analysis of advanced/metastatic breast cancer: decade report (2005–2015). Breast 2018;39:131–138. Kobayashi, 2016, Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer, Surgery today., 46, 821, 10.1007/s00595-015-1252-x Caswell-Jin, 2018, Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review, JNCI Cancer Spectr, 2 Hortobagyi, 2021, Ann Oncol, 32, S1290, 10.1016/j.annonc.2021.08.2090 Kaklamai, 2016, Clinical implications of the progression-free survival endpoint forTreatment of hormone receptor-positive advanced breast cancer, Oncol, 21, 922, 10.1634/theoncologist.2015-0366 MacEwan, 2019, The value of progression-free survival in metastatic breast cancer: results from a survey of patients and providers, MDM Policy Pract., 4 Spaich, 2018, Patient preferences regarding chemotherapy in metastatic breast cancer—a conjoint analysis for common taxanes, Front Oncol, 8 Mokhtari-Hessari, 2020, Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018, Health Qual Life Outcome, 18, 338, 10.1186/s12955-020-01591-x 2021, Current approaches and unmet needs in the treatment of metastatic triple-negative breast cancer, AJMC, 27, S87 2020, Patient insights: 2020 cancer experience registry report 2012, Patient-reported outcomes (PRO) in patients with metastatic breast cancer (MBC) from the VIRGO observational cohort study (OCS), J Clin Oncol, 30, 111 Reed, 2012, Quality of life and experience of care in women with metastatic breast cancer: a cross-sectional survey, J Pain Symptom Manag, 43, 747, 10.1016/j.jpainsymman.2011.05.005 Turner-Bowker, 2016, The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature, Curr Med Res Opin, 32, 1709, 10.1080/03007995.2016.1205005 Pe, 2018, Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review, Lancet Oncol, 19, e459, 10.1016/S1470-2045(18)30418-2 Battisti, 2021, Bridging the Age Gap in breast cancer: impact of chemotherapy on quality of life in older women with early breast cancer, European journal of cancer (Oxford, England : 1990), 144, 269, 10.1016/j.ejca.2020.11.022 Biganzoli, 2012, Management of elderly patients with breast cancer: updated recommendations of the international society of geriatric oncology (SIOG) and European society of breast cancer Specialists (EUSOMA), Lancet Oncol, 13, e148, 10.1016/S1470-2045(11)70383-7 Glaser, 2009 Gubrium, 2002 MSv, 2020, Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology, Cancer Epidemiology, Biomarkers & Prevention., 126, 1605 Cohen, 2017, Three sets of case studies suggest logic and consistency challenges with value frameworks, Value Health : the journal of the International Society for Pharmacoeconomics and Outcomes Research., 20, 193, 10.1016/j.jval.2016.11.012 Mortesen, 2018, Quality of life and care needs in women with estrogen positive metastatic breast cancer: a qualitative study, Acta Oncol., 57, 146, 10.1080/0284186X.2017.1406141 Mv, 2020, Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology, Cancer., 126, 1605, 10.1002/cncr.32730 Thorne, 2014, Changing communication needs and preferences across the cancer care trajectory: insights from the patient perspective, Support Care Cancer, 22, 1009, 10.1007/s00520-013-2056-4 Thorne, 2012, Patient perceptions of communications on the threshold of cancer survivorship: implications for provider responses, J Cancer Surviv., 6, 229, 10.1007/s11764-012-0216-z Zeuner, 2015, Physicians' perceptions of shared decision-making behaviours: a qualitative study demonstrating the continued chasm between aspirations and clinical practice, Health Expect : An International Journal of Public Participation in Health Care and Health Policy., 18, 2465, 10.1111/hex.12216 Arora, 2003, Interacting with cancer patients: the significance of physicians' communication behavior, Soc Sci Med, 57, 791, 10.1016/S0277-9536(02)00449-5 McCormack, 2011, Measuring patient-centered communication in cancer care: a literature review and the development of a systematic approach, Soc Sci Med, 72, 1085, 10.1016/j.socscimed.2011.01.020 Mohile, 2018, Improving communication with older patients with cancer using geriatric assessment (GA): a University of Rochester NCI Community Oncology Research Program (NCORP) cluster randomized controlled trial (CRCT), J Clin Oncol, 36, 10.1200/JCO.2018.36.18_suppl.LBA10003 Shih, 2017, A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment, Cancer., 123, 928, 10.1002/cncr.30423 Rocque, 2019, What is important when making treatment decisions in metastatic breast cancer? A qualitative analysis of decision-making in patients and oncologists, Oncol, 24, 1313, 10.1634/theoncologist.2018-0711 Fallowfield, 2008, Treatment decision-making in breast cancer: the patient–doctor relationship, Breast Cancer Res Treat, 112, 5, 10.1007/s10549-008-0077-3 Lux, 2013, Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors, Breast Cancer Res Treat, 139, 429, 10.1007/s10549-013-2557-3 Thiel, 2012, Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians, Breast Cancer Res Treat, 135, 811, 10.1007/s10549-012-2218-y Brom, 2017, Challenges in shared decision making in advanced cancer care: a qualitative longitudinal observational and interview study, Health Expect, 20, 69, 10.1111/hex.12434 Yousuf Zafar, 2016, Financial toxicity of cancer care: it's time to intervene, J Natl Cancer Inst., 108, 10.1093/jnci/djv370 Gupta, 2022, The time toxicity of cancer treatment, J Clin Oncol, 40, 1611, 10.1200/JCO.21.02810 Ishikawa, 2005, How applicable are western models of patient-physician relationship in Asia?: changing patient-physician relationship in contemporary Japan, Int J Jpn Sociol, 14, 84, 10.1111/j.1475-6781.2005.00070.x Pun, 2018, Health professional-patient communication practices in East Asia: an integrative review of an emerging field of research and practice in Hong Kong, South Korea, Japan, Taiwan, and Mainland China, Patient Educ Counsel, 101, 1193, 10.1016/j.pec.2018.01.018 Matusitz, 2015, Doctor-patient communication styles: a comparison between the United States and three asian countries, J Hum Behav Soc Environ, 25, 871, 10.1080/10911359.2015.1035148 Vasileiou, 2018, Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period, BMC Med Res Methodol, 18 Granek, 2019, Oncology health care professionals' perspectives on the causes of mental health distress in cancer patients, Psycho Oncol, 28, 1695, 10.1002/pon.5144 Pai, 2015, Oncology nurse navigator programme - a narrative review, Journal of Health and Allied Sciences NU., 5, 103, 10.1055/s-0040-1703877 Liu, 2019, Patient and oncology nurse preferences for the treatment options in advanced melanoma: a discrete choice experiment, Cancer Nurs, 42, 10.1097/NCC.0000000000000557